IDEXX LABORATORIES INC /DE Share-based Payment Arrangement, Expense, Tax Benefit
IDEXX LABORATORIES INC /DE (IDXX) reported Share-based Payment Arrangement, Expense, Tax Benefit of $5.49 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2024-02-22
- IDEXX LABORATORIES INC /DE share-based payment arrangement, expense, tax benefit for fiscal 2023 was $5.49M, a 17.80% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE share-based payment arrangement, expense, tax benefit for fiscal 2022 was $4.66M, a 1.61% decline from fiscal 2021.
- IDEXX LABORATORIES INC /DE share-based payment arrangement, expense, tax benefit for fiscal 2021 was $4.73M, a 19.39% increase from fiscal 2020.
- IDEXX LABORATORIES INC /DE share-based payment arrangement, expense, tax benefit for fiscal 2020 was $3.96M, a 18.43% decline from fiscal 2019.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|
| 2023-12-31 | $5.49M 10-K · filed 2024-02-22 |
| 2022-12-31 | $4.66M 10-K · filed 2024-02-22 |
| 2021-12-31 | $4.73M 10-K · filed 2024-02-22 |
| 2020-12-31 | $3.96M 10-K · filed 2023-02-16 |
| 2019-12-31 | $4.86M 10-K · filed 2022-02-16 |
| 2018-12-31 | $4.19M 10-K · filed 2021-02-12 |
| 2017-12-31 | $6.81M 10-K · filed 2020-02-14 |
| 2016-12-31 | $6.14M 10-K · filed 2019-02-15 |
| 2015-12-31 | $6.23M 10-K · filed 2018-02-16 |
| 2014-12-31 | $6.11M 10-K · filed 2017-02-17 |
| 2013-12-31 | $5.58M 10-K · filed 2016-02-17 |
| 2012-12-31 | $5.40M 10-K · filed 2015-02-17 |
| 2011-12-31 | $5.25M 10-K · filed 2014-02-18 |
| 2010-12-31 | $4.60M 10-K · filed 2013-02-19 |
| 2009-12-31 | $3.83M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |